en
Scientific article
English

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?

Published inExpert Review of Vaccines, vol. 17, no. 12, p. 1105-1110
Publication date2018
Abstract

The live-attenuated recombinant vesicular stomatitis virus vaccine expressing the glycoprotein (GP) of Zaire Ebola virus (rVSV-ZEBOV) has proven immunogenic in humans and effective in field studies. Yet long-term durability of vaccine responses is unknown.

Keywords
  • Ebola virus disease
  • Ebola
  • Vaccine
  • RVSV-ZEBOV
  • Immune response
  • Durability
  • Persistence
  • Seropositivity
Citation (ISO format)
CSAKI HUTTNER, Angela, SIEGRIST, Claire-Anne. Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know? In: Expert Review of Vaccines, 2018, vol. 17, n° 12, p. 1105–1110. doi: 10.1080/14760584.2018.1546582
Main files (1)
Article (Published version)
accessLevelPrivate
Identifiers
ISSN of the journal1476-0584
295views
0downloads

Technical informations

Creation09/13/2019 3:39:00 PM
First validation09/13/2019 3:39:00 PM
Update time03/15/2023 6:11:10 PM
Status update03/15/2023 6:11:10 PM
Last indexation01/17/2024 6:31:15 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack